Barclays PLC trimmed its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 50.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 602,850 shares of the company's stock after selling 626,102 shares during the period. Barclays PLC owned about 0.15% of agilon health worth $1,146,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. raised its holdings in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Inspire Investing LLC increased its position in shares of agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock valued at $413,000 after buying an additional 112,241 shares during the period. Cerity Partners LLC purchased a new stake in agilon health in the fourth quarter worth about $34,000. Geode Capital Management LLC boosted its position in agilon health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock valued at $13,168,000 after acquiring an additional 35,207 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new position in shares of agilon health during the 4th quarter worth approximately $111,000.
agilon health Stock Performance
Shares of AGL traded down $0.35 during trading hours on Friday, hitting $2.87. The stock had a trading volume of 6,081,257 shares, compared to its average volume of 4,901,572. The firm has a market capitalization of $1.19 billion, a PE ratio of -3.05 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The stock has a fifty day moving average price of $4.27 and a 200 day moving average price of $3.19.
agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.04. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business's revenue for the quarter was down 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.02) EPS. Analysts anticipate that agilon health, inc. will post -0.59 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on AGL shares. TD Cowen upped their price target on agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research note on Tuesday, April 15th. Cowen reiterated a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Barclays upped their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock an "underweight" rating in a report on Thursday. Stifel Nicolaus lifted their target price on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a report on Wednesday, February 26th. Finally, Citigroup upgraded agilon health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $4.89.
Read Our Latest Analysis on AGL
agilon health Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Recommended Stories
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
